Publication:
Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes

dc.contributor.authorBogas, Gador
dc.contributor.authorMayorga, Cristobalina
dc.contributor.authorMartín-Serrano, Ángela
dc.contributor.authorFernández-Santamaría, Rubén
dc.contributor.authorJiménez-Sánchez, Isabel M.
dc.contributor.authorAriza, Adriana
dc.contributor.authorBarrionuevo, Esther
dc.contributor.authorPosadas, Teresa
dc.contributor.authorSalas, María
dc.contributor.authorFernández, Tahía Diana
dc.contributor.authorTorres, María José
dc.contributor.authorMontañez, María Isabel
dc.contributor.authoraffiliation[Bogas,G; Mayorga,G; Martín-Serrano,A; Fernández-Santamaría,R; Jiménez-Sánchez,IM; Ariza,A; Barrionuevo,E; Posadas,T; Salas,M; Fernández,TD; Torres,MJ; Montañez,MI] Allergy Research Group, Instituto de Investigación Biomédica de Málaga- IBIMA, Hospital Civil, Málaga, Spain. [Bogas,G; Mayorga,G; Barrionuevo,E; Posadas,T; Salas,M; Torres,MJ] Allergy Unit, Hospital Regional Universitario de Málaga, Hospital Civil, Málaga, Spain. [Mayorga,G; Martín-Serrano,A; Jiménez-Sánchez,IM; Torres,MJ; Montañez,MI] Nanostructures for Diagnosing and Treatment of Allergic Diseases Laboratory, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Málaga, Spain. [Fernández,TD] Departamento de Biología Celular, Genética y Fisiología, Universidad de Málaga, Málaga, Spain. [Torres,MJ] Departamento de Medicina, Universidad de Málaga, Facultad de Medicina, Málaga, Spain.
dc.contributor.funderThe present study has been supported by the Institute of Health ‘‘Carlos III’’ (ISCIII) of MINECO (Grants cofunded by ERDF: ‘‘Una manera de hacer Europa’’: Grant ns. PI12/02529, PI15/01206, CP15/00103, PI17/01237, PI18/00095, RETIC ARADYAL RD16/0006/0001, Euronanomed Program AC19/00082; Andalusian Regional Ministry of Economy and Knowledge (Grants cofunded by ERDF: ‘‘Andalucía se mueve con Europa’’: Grant No. CTS-06603); Andalusian Regional Ministry of Health (Grant Nos. PI-0699–2011, PI-0179–2014, PE-0172–2018 cofunded by ERDF); and ‘‘Premio UNICAJA a la innovación en biomedicina y salud.’’ C.M. holds ‘Nicolas Monardes’ research contract by Andalusian Regional Ministry Health (Grant No. C-0044–2012 SAS2013). G.B. holds a “Juan Rodes” Grant (JR18/00054), M.I.M. holds a ‘‘Miguel Servet I’’ Grant (CP15/00103), and A.A. holds a ‘‘Sara Borrell’’ Grant (CD17/0146), all by ISCIII of MINECO (grants cofunded by European Social Fund: ‘‘El FSE invierte en futuro’’). R.F.S. holds a predoctoral Grant (PE-0172–2018) cofunded by ERDF.
dc.date.accessioned2022-04-26T13:01:47Z
dc.date.available2022-04-26T13:01:47Z
dc.date.issued2020-12-04
dc.description.abstractBackground Analysis of cross-reactivity is necessary for prescribing safe cephalosporins for penicillin allergic patients. Amoxicillin (AX) is the betalactam most often involved in immediate hypersensitivity reactions (IHRs), and cefadroxil (CX) the most likely cephalosporin to cross-react with AX, since they share the same R1 side chain, unlike cefuroxime (CO), with a structurally different R1. We aimed to analyse cross-reactivity with CX and CO in patients with confirmed IHRs to AX, including sIgE recognition to AX, CX, CO, and novel synthetic determinants of CX. Methods Fifty-four patients with confirmed IHRs to AX based on skin test (ST) and/or drug provocation test (DPT) were included. Serum sIgE to AX and benzylpenicillin was determined by Radioallergosorbent test (RAST). Two potential determinants of CX, involving intact or modified R1 structure, with open betalactam ring, were synthesised and sIgE evaluated by RAST inhibition assay. Results Tolerance to CX (Group A) was observed in 64.8% cases and cross-reactivity in 35.2% cases (Group B). Cross-reactivity with CO was only found in 1.8% cases from Group B. ST to CX showed a negative predictive value of 94.6%. RAST inhibition assays showed higher recognition to CX as well as to both synthetic determinants (66% of positive cases) in Group B. Conclusions Cross-reactivity with CX in AX allergic patients is 35%, being ST not enough for prediction. R1, although critical for recognition, is not the unique factor. The synthetic determinants of CX, 1-(HOPhG-Ser-Bu) and 2-(pyrazinone) are promising tools for determining in vitro cross-reactivity to CX in AX allergic patients. Background Betalactams (BLs) are the drugs most frequently involved in immediate (IgE-mediated) hypersensitivity reactions (IHRs) [1,2,3], which could be explained by their ability to act as haptens due to their high chemical reactivity against proteins [4, 5]. BL chemical structure is formed by a 4-membered ring (the so-called BL ring) that in penicillins is fused to a 5-membered thiazolidine ring, and in cephalosporins to a 6-membered dihydrothiazine ring (Fig. 1). These drugs have a side chain (R1) bound to the BL ring; besides, cephalosporins have a second side chain (R2) bound to the dihydrothiazine ring, whose chemical structures distinguish the different compounds [6, 7].es_ES
dc.description.versionYeses_ES
dc.identifier.citationBogas G, Mayorga C, Martín-Serrano Á, Fernández-Santamaría R, Jiménez-Sánchez IM, Ariza A, et al. Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes. Clin Transl Allergy. 2020 Dec 4;10(1):57es_ES
dc.identifier.doi10.1186/s13601-020-00368-1es_ES
dc.identifier.essn2045-7022
dc.identifier.pmcPMC7716594
dc.identifier.pmid33292516es_ES
dc.identifier.urihttp://hdl.handle.net/10668/3574
dc.journal.titleClinical and Translational Allergy
dc.language.isoen
dc.page.number14 p.
dc.publisherBioMed Central (BMC), Springer Naturees_ES
dc.relation.publisherversionhttps://ctajournal.biomedcentral.com/articles/10.1186/s13601-020-00368-1es_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAmoxicillines_ES
dc.subjectBetalactames_ES
dc.subjectCephalosporines_ES
dc.subjectCross-reactivityes_ES
dc.subjectDrug allergyes_ES
dc.subjectAntigenic determinantes_ES
dc.subjectSpecific IgEes_ES
dc.subjectAmoxicilinaes_ES
dc.subjectBeta-lactamases_ES
dc.subjectCefalosporinases_ES
dc.subjectHipersensibilidad a las Drogases_ES
dc.subjectReacciones cruzadases_ES
dc.subjectEpítoposes_ES
dc.subjectInmunoglobulina Ees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Penicillins::Penicillin G::Ampicillin::Amoxicillines_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Cephalosporinses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactamses_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Immune System Phenomena::Immune System Processes::Antigen-Antibody Reactions::Cross Reactionses_ES
dc.subject.meshMedical Subject Headings::Diseases::Immune System Diseases::Hypersensitivity::Drug Hypersensitivityes_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Biological Factors::Antigens::Epitopeses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Globulins::Serum Globulins::Immunoglobulins::Antibodies::Immunoglobulin Isotypes::Immunoglobulin Ees_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.titlePenicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopeses_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Bogas_PenicillinAndCephalosporin.pdf
Size:
1.46 MB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
Loading...
Thumbnail Image
Name:
Bogas_PenicillinAndCephalosporin_AdditionalFile.pdf
Size:
930.37 KB
Format:
Adobe Portable Document Format
Description:
Material suplementario